Home >> Marketplace Directory >> IHC-based kit for tumor invasiveness, 4/13:88

IHC-based kit for tumor invasiveness, 4/13:88

image_pdfCreate PDF

Oncomatrix’s DMTXinvaScan is an immunohistochemistry-based kit designed to diagnose and predict the invasiveness of pancreas, breast, lung, colon, and head and neck tumors.

The main component of DMTXinva-Scan is a monoclonal antibody that detects collagen XI-α1. Oncomatrix developed and clinically validated this antibody.

Oncomatrix, 34 94 401 53 06

CAP TODAY
X